chloroquine has been researched along with Arrhythmia in 48 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, the aim of study was to evaluate the influence of seven-month chloroquine treatment with a 250mg daily dose on arrhythmia, conduction disturbances as well as heart rate variability and repolarization parameters assessed in 24-hour Holter monitoring." | 7.73 | The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters. ( Chudzik, M; Cygankiewicz, I; Sysa-Jedrzejowska, A; Wozniacka, A; Wranicz, JK, 2006) |
| "Chloroquine poisoning in children, although infrequent, is extremely dangerous because of the narrow margin between therapeutic and toxic doses." | 7.68 | Chloroquine poisoning in a child. ( Bernard, WD; Kelly, JC; Knapp, J; Schultz, C; Wasserman, GS, 1990) |
| " In fact, two of the actually used drugs against SARS-CoV2, such as chloroquine and the combination lopinavir/ritonavir, might determine a QT (the time from the start of the Q wave to the end of the T wave) interval prolongation and they show several interactions with antiarrhythmic drugs and antipsychotic medications, making them prone to an increased risk of developing arrhythmias." | 5.12 | COVID-19 and the burning issue of drug interaction: never forget the ECG. ( Cameli, M; Cameli, P; Franchi, F; Mandoli, GE; Menci, D; Mondillo, S; Sciaccaluga, C; Sisti, N; Valente, S, 2021) |
| "A 58 year old woman on long term treatment with chloroquine for systemic lupus erythematosus presented with cardiac conduction disorders and heart failure with hypertrophic cardiomyopathy, which was confirmed by histology to be related to chloroquine toxicity." | 4.80 | Chloroquine cardiomyopathy with conduction disorders. ( Baguet, JP; Fabre, M; Tremel, F, 1999) |
| "We applied a set of in silico and in vitro assays, compliant with the Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm, to assess the risk of chloroquine (CLQ) or hydroxychloroquine (OH-CLQ)-mediated QT prolongation and Torsades de Pointes (TdP), alone and combined with erythromycin (ERT) and azithromycin (AZI), drugs repurposed during the first wave of coronavirus disease 2019 (COVID-19)." | 4.02 | Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19. ( Abernathy, M; Anderson, WD; Beattie, KA; Chaudhary, KW; Coulot, J; Delaunois, A; Gryshkova, V; Hebeisen, S; Holbrook, M; Kramer, J; Kuryshev, Y; Leishman, D; Lushbough, I; Passini, E; Redfern, WS; Rodriguez, B; Rossman, EI; Trovato, C; Valentin, JP; Wu, C, 2021) |
| "Neither diazepam nor other ligands for benzodiazepine binding sites protect against or attenuate chloroquine cardiotoxicity." | 3.96 | Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam. ( Hughes, DA, 2020) |
| "Chloroquine seems to play a protective role in the unexpected high rate of cardiac arrhythmias and conduction disturbances observed in SLE." | 3.80 | Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus. ( Bonfá, E; Borba, EF; Kalil-Filho, R; Martinelli Filho, M; Nishioka, S; Pedrosa, A; Ramires, JA; Teixeira, RA; Viana, VS, 2014) |
| " Therefore, the aim of study was to evaluate the influence of seven-month chloroquine treatment with a 250mg daily dose on arrhythmia, conduction disturbances as well as heart rate variability and repolarization parameters assessed in 24-hour Holter monitoring." | 3.73 | The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters. ( Chudzik, M; Cygankiewicz, I; Sysa-Jedrzejowska, A; Wozniacka, A; Wranicz, JK, 2006) |
| "Chloroquine poisoning in children, although infrequent, is extremely dangerous because of the narrow margin between therapeutic and toxic doses." | 3.68 | Chloroquine poisoning in a child. ( Bernard, WD; Kelly, JC; Knapp, J; Schultz, C; Wasserman, GS, 1990) |
| " However, some of these medications have potential cardiac adverse effects." | 2.66 | Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol. ( Lazar, S; Naksuk, N; Peeraphatdit, TB, 2020) |
| "In the largest reported cohort of coronavirus disease 2019 patients to date treated with chloroquine/hydroxychloroquine±azithromycin, no instances of Torsade de pointes, or arrhythmogenic death were reported." | 1.56 | Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection. ( Beldner, S; Chang, D; Chinitz, J; Epstein, LM; Gabriels, J; Goldner, B; Ismail, H; John, R; Mahmood, E; Makker, P; Mansoor, A; Mitra, R; Mountantonakis, S; Saleh, M; Skipitaris, N; Soo Kim, B; Willner, J, 2020) |
| "Due to potential arrhythmia risk from observed QT prolongation, alternans was assessed in the anesthetized guinea pig after azithromycin or chloroquine alone and after combination treatment at clinically relevant concentrations proposed for the management of malaria." | 1.34 | Azithromycin/chloroquine combination does not increase cardiac instability despite an increase in monophasic action potential duration in the anesthetized guinea pig. ( Deng, S; Duncan, JN; Dunne, M; Fossa, AA; Wisialowski, T, 2007) |
| "Life-threatening cardiac arrhythmias may be the first sign of overdosage." | 1.26 | Intentional chloroquine overdosage. ( Britton, WJ; Kevau, IH, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (41.67) | 18.7374 |
| 1990's | 2 (4.17) | 18.2507 |
| 2000's | 3 (6.25) | 29.6817 |
| 2010's | 4 (8.33) | 24.3611 |
| 2020's | 19 (39.58) | 2.80 |
| Authors | Studies |
|---|---|
| Thomet, U | 1 |
| Amuzescu, B | 1 |
| Knott, T | 1 |
| Mann, SA | 1 |
| Mubagwa, K | 1 |
| Radu, BM | 1 |
| Souza-Silva, MVR | 1 |
| Pereira, DN | 1 |
| Pires, MC | 1 |
| Vasconcelos, IM | 1 |
| Schwarzbold, AV | 1 |
| Vasconcelos, DH | 1 |
| Pereira, EC | 1 |
| Manenti, ERF | 1 |
| Costa, FR | 1 |
| Aguiar, FC | 1 |
| Anschau, F | 1 |
| Bartolazzi, F | 1 |
| Nascimento, GF | 1 |
| Vianna, HR | 1 |
| Batista, JDL | 1 |
| Machado-Rugolo, J | 1 |
| Ruschel, KB | 1 |
| Ferreira, MAP | 1 |
| Oliveira, LS | 1 |
| Menezes, LSM | 1 |
| Ziegelmann, PK | 1 |
| Tofani, MGT | 1 |
| Bicalho, MAC | 1 |
| Nogueira, MCA | 1 |
| Guimarães-Júnior, MH | 1 |
| Aguiar, RLO | 1 |
| Rios, DRA | 1 |
| Polanczyk, CA | 1 |
| Marcolino, MS | 1 |
| Juurlink, DN | 1 |
| Lentini, G | 1 |
| Cavalluzzi, MM | 1 |
| Habtemariam, S | 1 |
| Saleh, M | 1 |
| Gabriels, J | 1 |
| Chang, D | 1 |
| Soo Kim, B | 1 |
| Mansoor, A | 1 |
| Mahmood, E | 1 |
| Makker, P | 1 |
| Ismail, H | 1 |
| Goldner, B | 1 |
| Willner, J | 1 |
| Beldner, S | 1 |
| Mitra, R | 1 |
| John, R | 1 |
| Chinitz, J | 1 |
| Skipitaris, N | 1 |
| Mountantonakis, S | 1 |
| Epstein, LM | 1 |
| Monzani, A | 1 |
| Genoni, G | 1 |
| Scopinaro, A | 1 |
| Pistis, G | 1 |
| Kozel, D | 1 |
| Secco, GG | 1 |
| Naksuk, N | 1 |
| Lazar, S | 1 |
| Peeraphatdit, TB | 1 |
| Hughes, DA | 1 |
| Asensio, E | 1 |
| Acunzo, R | 1 |
| Uribe, W | 1 |
| Saad, EB | 1 |
| Sáenz, LC | 1 |
| Medeiros-Domingo, A | 1 |
| Carrasco, OF | 1 |
| Berni-Betancourt, A | 1 |
| Norinder, U | 1 |
| Tuck, A | 1 |
| Norgren, K | 1 |
| Munic Kos, V | 1 |
| Sciaccaluga, C | 1 |
| Cameli, M | 1 |
| Menci, D | 1 |
| Mandoli, GE | 1 |
| Sisti, N | 1 |
| Cameli, P | 1 |
| Franchi, F | 1 |
| Mondillo, S | 1 |
| Valente, S | 1 |
| Kim, YS | 1 |
| Lee, SY | 1 |
| Yoon, JW | 1 |
| Kim, D | 1 |
| Yu, S | 1 |
| Kim, JS | 1 |
| Kim, JH | 1 |
| Varshneya, M | 1 |
| Irurzun-Arana, I | 1 |
| Campana, C | 1 |
| Dariolli, R | 1 |
| Gutierrez, A | 1 |
| Pullinger, TK | 1 |
| Sobie, EA | 1 |
| Alkasir, A | 1 |
| Lippmann, S | 1 |
| Wong, AO | 1 |
| Gurung, B | 1 |
| Wong, WS | 1 |
| Mak, SY | 1 |
| Tse, WW | 1 |
| Li, CM | 1 |
| Lieu, DK | 1 |
| Costa, KD | 1 |
| Li, RA | 1 |
| Hajjar, RJ | 1 |
| Ehrlich, H | 1 |
| Elkbuli, A | 1 |
| Delaunois, A | 1 |
| Abernathy, M | 1 |
| Anderson, WD | 1 |
| Beattie, KA | 1 |
| Chaudhary, KW | 1 |
| Coulot, J | 1 |
| Gryshkova, V | 1 |
| Hebeisen, S | 1 |
| Holbrook, M | 1 |
| Kramer, J | 1 |
| Kuryshev, Y | 1 |
| Leishman, D | 1 |
| Lushbough, I | 1 |
| Passini, E | 1 |
| Redfern, WS | 1 |
| Rodriguez, B | 1 |
| Rossman, EI | 1 |
| Trovato, C | 1 |
| Wu, C | 1 |
| Valentin, JP | 1 |
| Ogah, OS | 1 |
| Umuerri, EM | 1 |
| Adebiyi, A | 1 |
| Orimolade, OA | 1 |
| Sani, MU | 1 |
| Ojji, DB | 1 |
| Mbakwem, AC | 1 |
| Stewart, S | 1 |
| Sliwa, K | 1 |
| Luo, C | 1 |
| Wang, K | 1 |
| Liu, T | 1 |
| Zhang, H | 2 |
| Teixeira, RA | 1 |
| Borba, EF | 1 |
| Pedrosa, A | 1 |
| Nishioka, S | 1 |
| Viana, VS | 1 |
| Ramires, JA | 1 |
| Kalil-Filho, R | 1 |
| Bonfá, E | 1 |
| Martinelli Filho, M | 1 |
| Karathanos, TV | 1 |
| Boyle, PM | 1 |
| Trayanova, NA | 1 |
| El Harchi, A | 1 |
| McPate, MJ | 1 |
| Zhang, Yh | 1 |
| Hancox, JC | 1 |
| Phipps, C | 1 |
| Chan, K | 1 |
| Teo, F | 1 |
| Ponampalam, R | 1 |
| BURRELL, ZL | 1 |
| MARTINEZ, AC | 1 |
| YU, KJ | 2 |
| HSU, CY | 2 |
| HUANG, MH | 2 |
| CH'EN, HM | 1 |
| CHOU, CL | 1 |
| BASSET, A | 1 |
| MOINS, H | 1 |
| ORTOLANI, G | 1 |
| GIULIANI, V | 1 |
| ELISEO, V | 1 |
| SOKOLOV-PONOMAREVA, OD | 1 |
| BEREZHKOV, LF | 1 |
| SANABRIA, A | 1 |
| CARBONELL, LM | 1 |
| SOTO, R | 1 |
| Wozniacka, A | 1 |
| Cygankiewicz, I | 1 |
| Chudzik, M | 1 |
| Sysa-Jedrzejowska, A | 1 |
| Wranicz, JK | 1 |
| Fossa, AA | 1 |
| Wisialowski, T | 1 |
| Duncan, JN | 1 |
| Deng, S | 1 |
| Dunne, M | 1 |
| Baguet, JP | 1 |
| Tremel, F | 1 |
| Fabre, M | 1 |
| Mono, G | 1 |
| Kuhn, E | 1 |
| Swift, A | 1 |
| Karmazyn, M | 1 |
| Horrobin, DF | 1 |
| Manku, MS | 1 |
| Karmali, RA | 1 |
| Morgan, RO | 1 |
| Ally, AI | 1 |
| Singh, A | 1 |
| Singh, N | 1 |
| Singh, J | 1 |
| Britton, WJ | 1 |
| Kevau, IH | 1 |
| Charles, D | 1 |
| Ducloux, M | 1 |
| Descamps, DP | 1 |
| Norman, P | 1 |
| Kelly, JC | 1 |
| Wasserman, GS | 1 |
| Bernard, WD | 1 |
| Schultz, C | 1 |
| Knapp, J | 1 |
| Jurik, AG | 1 |
| Møller, P | 1 |
| Sogani, RK | 1 |
| Sharma, DK | 1 |
| Gupta, V | 1 |
| Alekseev, GK | 1 |
| Aviado, DM | 1 |
| Sadavongvivad, C | 1 |
| Cambar, P | 1 |
| Ayitey-Smith, E | 1 |
| Boye, GL | 1 |
| Nichani, N | 1 |
| Lewis, RA | 1 |
| Don Michael, TA | 1 |
| Aiwazzadeh, S | 1 |
| Sagardiluz, J | 1 |
| Clèdes, J | 1 |
| Potaux, L | 1 |
| Favarel-Garrigues, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals (ELEVATE Trial)[NCT04340349] | Early Phase 1 | 214 participants (Anticipated) | Interventional | 2021-02-01 | Enrolling by invitation | ||
| Safety and Efficacy of Post-exposure Prophylaxis With Hydroxychloroquine (HCQ) for the Prevention of COVID-19 in High-risk Older Individuals in Long-term and Specialized Care: A Double-blind Randomized Control Trial[NCT04397328] | Phase 3 | 336 participants (Anticipated) | Interventional | 2020-05-19 | Not yet recruiting | ||
| Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study[NCT02932007] | Phase 2 | 40 participants (Anticipated) | Interventional | 2017-03-28 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for chloroquine and Arrhythmia
| Article | Year |
|---|---|
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
Topics: Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infe | 2020 |
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
Topics: Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infe | 2020 |
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
Topics: Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infe | 2020 |
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
Topics: Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infe | 2020 |
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antimalarials; Arrhythmias, Cardiac; Betacoronavirus; | 2020 |
Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence.
Topics: Adult; Aged; Antimalarials; Arrhythmias, Cardiac; Azithromycin; Chloroquine; Coronavirus Infections; | 2020 |
Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Che | 2020 |
COVID-19 and the burning issue of drug interaction: never forget the ECG.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral | 2021 |
SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.
Topics: Acute Coronary Syndrome; Africa; Antimalarials; Arrhythmias, Cardiac; Cardiovascular Diseases; Chlor | 2021 |
Chloroquine cardiomyopathy with conduction disorders.
Topics: Antirheumatic Agents; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Chloroquine; Echocardiogra | 1999 |
[Cardiotoxic effects of drugs and various other substances. A review].
Topics: Adrenergic Agonists; Amphetamine; Antimony; Arrhythmias, Cardiac; Arsenic Poisoning; Catecholamines; | 1978 |
40 other studies available for chloroquine and Arrhythmia
| Article | Year |
|---|---|
Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept.
Topics: Action Potentials; Antiviral Agents; Arrhythmias, Cardiac; Biological Assay; Chloroquine; Computer S | 2021 |
Real-Life Data on Hydroxychloroquine or Chloroquine with or Without Azithromycin in COVID-19 Patients: A Retrospective Analysis in Brazil.
Topics: Aged; Arrhythmias, Cardiac; Azithromycin; Brazil; Chloroquine; Cohort Studies; COVID-19; COVID-19 Dr | 2023 |
COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.
Topics: Antimalarials; Antiviral Agents; Arrhythmias, Cardiac; Betacoronavirus; Cardiotoxicity; Chloroquine; | 2020 |
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.
Topics: Anti-Bacterial Agents; Antimalarials; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Chloroqui | 2020 |
QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine.
Topics: Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Cardiotoxicity; Chloroquine; Coronavirus Infec | 2020 |
Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam.
Topics: Animals; Arrhythmias, Cardiac; Benzodiazepinones; Cardiotoxicity; Chloroquine; Clonazepam; Coronavir | 2020 |
Potential pro-arrhythmic effects of pharmacotherapy against SARS-CoV-2.
Topics: Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Chloroquine; Coronavirus Infections; COVID-19; | 2020 |
Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic stem cell-derived cardiomyocytes.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Azithromycin; Cardiotoxicity; Cell Differentiation | 2020 |
Investigational Treatments for COVID-19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions.
Topics: Action Potentials; Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Chloroquine; COVID-19; COVI | 2021 |
COVID-19 and Cardiac Concerns for Psychiatric Patients.
Topics: Antidepressive Agents; Antiviral Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrioventricular | 2020 |
Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues.
Topics: Anti-Bacterial Agents; Antimalarials; Arrhythmias, Cardiac; Azithromycin; Chloroquine; COVID-19 Drug | 2021 |
Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions.
Topics: Angiotensin-Converting Enzyme 2; Anti-Bacterial Agents; Antimalarials; Arrhythmias, Cardiac; Azithro | 2021 |
Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19.
Topics: Animals; Antimalarials; Arrhythmias, Cardiac; Chloroquine; CHO Cells; COVID-19 Drug Treatment; Crice | 2021 |
Computational Analysis of the Action of Chloroquine on Short QT Syndrome Variant 1 and Variant 3 in Human Ventricles.
Topics: Action Potentials; Arrhythmias, Cardiac; Chloroquine; Electrocardiography; Heart Conduction System; | 2018 |
Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus.
Topics: Adult; Anti-Arrhythmia Agents; Antirheumatic Agents; Arrhythmias, Cardiac; Brazil; Cardiotonic Agent | 2014 |
Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach.
Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chloroquine; Computer Simulation; E | 2014 |
Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome.
Topics: Action Potentials; Animals; Antirheumatic Agents; Arrhythmias, Cardiac; Chloroquine; CHO Cells; Cric | 2009 |
Fatal chloroquine poisoning: a rare cause of sudden cardiac arrest.
Topics: Acute Disease; Adult; Antimalarials; Arrhythmias, Cardiac; Chloroquine; Death, Sudden, Cardiac; Drug | 2011 |
Chloroquine and hydroxychloroquine in the treatment of cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Chloroquine; Humans; Hydroxychloroquine | 1958 |
[Therapeutic effect of chloroquine on cardiac arrhythmias].
Topics: Arrhythmias, Cardiac; Chloroquine; Humans | 1959 |
Chloroquine in treatment of cardiac arrhythmias: a preliminary report.
Topics: Arrhythmias, Cardiac; Chloroquine | 1959 |
Clinical assessment of therapeutic effects of chloroquine on cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Chloroquine | 1960 |
[Reduction of complete arrhythmia by chloroquine].
Topics: Arrhythmias, Cardiac; Chloroquine; Humans | 1961 |
[Chloroquine and hydroxychloroquine in the therapy of arrhythmia due to fibrillation].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Chloroquine; Heart Conduc | 1963 |
[SOME NEW DRUGS IN THE TREATMENT OF RHEUMATIC CHILDREN].
Topics: Adolescent; Alkaloids; Anabolic Agents; Antithyroid Agents; Arrhythmias, Cardiac; Cardiovascular Dis | 1964 |
Action of procainamide, quinidine and chloroquine upon the conduction system of the dog's heart (histochemical study).
Topics: Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Chloroquine; Dog | 1959 |
The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Arrhythmias, Cardiac; Chloroquine; El | 2006 |
Azithromycin/chloroquine combination does not increase cardiac instability despite an increase in monophasic action potential duration in the anesthetized guinea pig.
Topics: Action Potentials; Anesthesia; Animals; Antimalarials; Arrhythmias, Cardiac; Azithromycin; Blood Pre | 2007 |
Low prostaglandin concentrations cause cardiac rhythm disturbances. Effect reversed by low levels of copper or chloroquine.
Topics: Animals; Arrhythmias, Cardiac; Chloroquine; Copper; Drug Synergism; Heart Conduction System; Indomet | 1978 |
Oral chloroquine therapy in premature beats.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Chloroquine; Female; Humans; Male; Middle Aged | 1978 |
Intentional chloroquine overdosage.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Chloroquine; Electrocardiography; Female; Heart; Humans; Ma | 1978 |
[The heart in severe chloroquine poisoning. Apropos of 4 cases].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Chloroquine; Female; Heart; Heart Conduction System; Humans | 1975 |
Chloroquine poisoning in a child.
Topics: Apnea; Arrhythmias, Cardiac; Chloroquine; Female; Humans; Infant; Poisoning; Seizures | 1990 |
Atrioventricular conduction time in rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Arthritis, Rheumatoid; Atrioventricular Node; Cardiom | 1985 |
Cardiovascular collapse following small dose of chloroquin in healthy young adult.
Topics: Adult; Arrhythmias, Cardiac; Chloroquine; Humans; Male | 1986 |
[Observations on the treatment of certain forms of arrhythmia using contemporary methods].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Card | 1968 |
Cardiopulmonary effects of antimalarial drugs. 1. 4-Aminoquinolines: chloroquine quinetholate.
Topics: Anaphylaxis; Animals; Arrhythmias, Cardiac; Asthma; Blood Pressure; Chloroform; Chloroquine; Dopamin | 1970 |
Effect of hyperthermia on acute chloroquine toxicity in rabbits.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Chloroquine; Electrocardiography; Female; Fever; Male | 1974 |
The effects of acute chloroquine poisoning with special reference to the heart.
Topics: Adolescent; Animals; Antidotes; Arrhythmias, Cardiac; Bradycardia; Chloroquine; Dogs; Epinephrine; H | 1970 |
[Cardiac complications in acute poisoning].
Topics: Adolescent; Adult; Amitriptyline; Arrhythmias, Cardiac; Child; Child, Preschool; Chloroquine; Digita | 1967 |